NASP, SmartBrief partner to launch first news brief dedicated to specialty pharmacy industry

NewsGuard 100/100 Score

The National Association of Specialty Pharmacy (NASP) and SmartBrief recently partnered to deliver a daily newsletter providing the specialty pharmacy industry with a snapshot of the top news in the industry. The purpose of this brief is to keep specialty pharmacies, pharmaceutical and biotechnology manufacturers, GPOs, distributors and other specialty pharmacy stakeholders engaged in and informed. This free resource will launch on April 27, 2015.

"We are looking forward to the launch of our first news brief solely dedicated to the specialty pharmacy industry," said Rick Stamberger, CEO of SmartBrief. "With generous guidance from NASP, Specialty Pharmacy SmartBrief will provide the industry with its top news stories every day, all while further solidifying NASP's role as industry thought leaders."

Specialty Pharmacy SmartBrief will provide the day's trending news on legislation, regulation, clinical and research advancements, and technology updates within the industry. Specialty Pharmacy SmartBrief will also capture the latest events, resources and updates from NASP.

"NASP is pleased to provide the new professionally prepared resource to members and others in the specialty pharmacy industry," said NASP President Mike Ellis, RPh. "The NASP SmartBrief will be a quick read, providing a easy way to stay abreast of news stories relevant to all specialty pharmacy stakeholders."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Milestone in diabetes treatment: Transgenic cow produces human insulin in milk